DLA Piper advises LLR Partners in strategic growth investment in TruTechnologies™

DLA Piper advised LLR Partners, a lower middle market private equity firm, in its strategic growth investment in TruTechnologies™, a leading provider of real-time clinical trial oversight.

LLR’s growth capital and value creation resources will be dedicated to helping TruTechnologies’ expansion as it transforms how pharmaceutical companies, together with clinical research organizations and research sites, oversee, monitor, and manage biological samples and study workflows throughout the clinical trial lifecycle.

The DLA Piper team was led by partner Eric Grossman (Northern Virginia) and included partners Matt Servies (Atlanta) and Betsy Burkhard (Boston), of counsels Melissa Sampson (Washington, DC) and Thomas Hendershot (Northern Virginia), and associates Kaitlyn Pettet (Atlanta) and Michelle Bauer (Washington, DC).

With more than 225 global lawyers who provide strategic counsel to private equity funds and their industry-leading portfolio companies, DLA Piper’s Private Equity practice has the capacity, experience and relationships to help drive value across the investment life cycle by delivering responsive, efficient and integrated solutions around the world. The Private Equity practice is also the #2 most active law firm globally by PitchBook.